Fortitude Family Office’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87K Sell
25
-3
-11% -$216 ﹤0.01% 1504
2026
Q1
$1.99K Buy
28
+19
+211% +$1.3K ﹤0.01% 1284
2025
Q4
$533 Sell
9
-5
-36% -$271 ﹤0.01% 1685
2025
Q3
$773 Hold
14
– – ﹤0.01% 1635
2025
Q2
$603 Buy
+14
New +$540 ﹤0.01% 1710
2024
Q3
– Sell
-100
Closed -$4.37K – 1252
2024
Q2
$4.37K Hold
100
– – ﹤0.01% 643
2024
Q1
$4.77K Hold
100
– – ﹤0.01% 628
2023
Q4
$4.72K Buy
+100
New +$4.15K ﹤0.01% 675

Other funds holding NGVT

Fortitude Family Office's NGVT Position: Q2 2026 in Review

Fortitude Family Office reduced its Ingevity (NGVT) stake by 11% in Q2 2026, selling an estimated $216 and leaving 25 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

Fortitude Family Office first reported a position in NGVT in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.77K in Q1 2024. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Fortitude Family Office held 25 shares of Ingevity worth $1.87K as of Q2 2026.
  • Fortitude Family Office sold 3 Ingevity shares in Q2 2026, an estimated $216.
  • Ingevity made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1504 holding.
  • Fortitude Family Office first reported a position in Ingevity in Q4 2023 and has held it in 8 quarters since.
  • Fortitude Family Office's Ingevity position peaked at $4.77K in Q1 2024.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.